Kupando
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $27M
Investors
- 7
About Kupando
Based in Brandenburg, Germany, and founded in 2018, Kupando GmbH is a biopharmaceutical company that develops TLR 4/7 agonists that stimulate innate immunity. The biopharmaceutical company is working on the development of TLR 4/7 agonists, that targets Toll-Like Receptors (TLRs) responsible for the detection of cancer and infectious molecules, and for the subsequent activation of the innate immune system. The company’s KUP101 is the only TLR 4/7 agonist in development and consists of TLR 4 agonist and a TLR 7 agonist co-encapsulated in a liposomal formulation this compound induces a broad immune response, which will facilitate its development as an anti-tumor agent in combination with other anti-tumor modalities, or a prophylactic vaccine for infectious diseases. This provides a multitude of options for administration routes and applications in Oncology and other infectious diseases.
Who invested in Kupando
7 investors across 2 rounds
See all investors in Kupando
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kupando
Who invested in Kupando?
Kupando has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kupando raised?
Kupando has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kupando last raise money?
Kupando's most recent round on record is a Series A, in Mar 2026.
What does Kupando do?
Based in Brandenburg, Germany, and founded in 2018, Kupando GmbH is a biopharmaceutical company that develops TLR 4/7 agonists that stimulate innate immunity.
Where is Kupando headquartered?
Kupando is headquartered in Germany.
Which VCs invest in companies like Kupando?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Kupando's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kupando? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.